title: Mammaglobin-A immunohistochemistry in primary central nervous system neoplasms and intracranial metastatic breast carcinoma.
abstract: Metastases represent the most common type of intracranial neoplasm. In women, 30% of such tumors derive from breast carcinoma. In neurosurgical cases with ambiguous cellular morphology and/or limited biopsy material, immunohistochemistry (IHC) is often performed to distinguish metastases from primary central nervous system (CNS) neoplasms. IHC for mammaglobin-A (MGA), a protein expressed in a majority of breast carcinomas, is commonly applied in this setting, but its utility for distinguishing primary CNS neoplasms from metastatic breast carcinoma is unknown; the reactivity of MGA in primary and metastatic CNS neoplasms has never been described. Here, we describe the frequency and patterns of IHC reactivity for MGA in metastatic and primary CNS neoplasms from patients with well-documented histories of breast carcinoma. Following a published protocol previously applied to non-CNS neoplasms, MGA staining of moderate to strong intensity within 5% or more of a neoplasm was considered positive. On the basis of these criteria, 3 of 12 (25.0%) glioblastomas, 1 of 10 (10.0%) meningiomas, and 47 of 95 (49.5%) metastases were positive. Importantly, the cytoarchitectural staining characteristics among all 4 MGA-positive primary CNS neoplasms (cytoplasmic and nuclear) differed from those of the metastases (cytoplasmic and membranous). These findings suggest that MGA IHC staining intensity and distribution can distinguish metastases from primary CNS neoplasms (P=0.0086) in women with a history of breast carcinoma but also indicate that cytologic staining patterns must be interpreted for more accurate tumor classification.
authors: Department of Pathology and Immunology, Division of Neuropathology, Washington University School of Medicine, St Louis, MO.
authors: Patrick J
authors: PJ
authors: Cimino
authors: Richard J
authors: RJ
authors: Perrin
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D001932:Brain Neoplasms / Q000145:classification / Q000378:metabolism / Q000473:pathology / Q000556:secondary; D001943:Breast Neoplasms / Q000145:classification / Q000378:metabolism / Q000473:pathology; D005260:Female; D005909:Glioblastoma / Q000145:classification / Q000378:metabolism / Q000473:pathology; D006801:Humans; D060785:Mammaglobin A / Q000378:metabolism*; D008577:Meningeal Neoplasms / Q000145:classification / Q000378:metabolism / Q000473:pathology; D008579:Meningioma / Q000145:classification / Q000378:metabolism / Q000473:pathology; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000378:metabolism*; D012189:Retrospective Studies
chemical_list: D014408:Biomarkers, Tumor; D060785:Mammaglobin A; D009363:Neoplasm Proteins
references: Mod Pathol. 2007 Aug;20(8):864-70
references: 17541441
references: J Neurooncol. 2007 Dec;85(3):281-7
references: 17571214
references: Neurosurgery. 1995 Sep;37(3):496-503; discussion 503-4
references: 7501116
references: Thorax. 2006 Mar;61(3):271
references: 16517588
references: Hum Pathol. 2013 Apr;44(4):628-35
references: 23084633
references: Hum Pathol. 1997 Aug;28(8):938-43
references: 9269830
references: Clin Chem. 2002 Aug;48(8):1362-4
references: 12142396
references: Cancer Res. 1996 Feb 15;56(4):860-5
references: 8631025
references: Arch Pathol Lab Med. 2003 Oct;127(10):1330-4
references: 14521461
references: Acta Neuropathol. 1993;86(5):473-9
references: 7906070
references: BMC Cancer. 2006 Apr 09;6:88
references: 16603086
references: Am J Surg Pathol. 2010 May;34(5):599-608
references: 20410810
references: Cancer Res. 1999 Jul 1;59(13):3028-31
references: 10397237
references: Adv Exp Med Biol. 2012;746:26-40
references: 22639157
references: Lung Cancer. 2003 Jul;41(1):49-56
references: 12826312
references: Cancer Res. 1994 Sep 1;54(17):4598-602
references: 8062249
references: Int J Gynecol Pathol. 2008 Jul;27(3):418-25
references: 18580321
references: Clin Neuropharmacol. 1984;7(4):338-42
references: 6509443
references: Int J Clin Exp Pathol. 2009;2(4):384-9
references: 19158935
references: Brain Res Bull. 2001 Sep 1;56(1):43-8
references: 11604247
references: J Neurooncol. 2008 Nov;90(2):223-8
references: 18648908
references: J Pathol. 2001 Sep;195(2):186-90
references: 11592097
references: Clin Biochem. 2004 Apr;37(4):249-57
references: 15003725
references: Nat Rev Drug Discov. 2012 Jun 01;11(6):479-97
references: 22653217
references: Arch Pathol Lab Med. 2011 Aug;135(8):975-83
references: 21809988
references: Acta Neuropathol. 2012 Feb;123(2):205-22
references: 22212630
references: Ann N Y Acad Sci. 2000;923:78-89
references: 11193781
references: Neurosurgery. 1993 Aug;33(2):212-7; discussion 217-8
references: 8367042
references: Mod Pathol. 2007 Feb;20(2):208-14
references: 17192791
references: Am J Clin Pathol. 2007 Jan;127(1):103-13
references: 17145637
references: Arch Pathol Lab Med. 2008 Feb;132(2):239-43
references: 18251583
references: J Mol Diagn. 2004 May;6(2):90-5
references: 15096563